ACADIA Pharmaceuticals Inc.
US ˙ NasdaqGS ˙ US0042251084

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Glenn Baity. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Glenn Baity har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ACAD / ACADIA Pharmaceuticals Inc. EVP AND GC 28.125
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Glenn Baity. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ACAD / ACADIA Pharmaceuticals Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ACAD / ACADIA Pharmaceuticals Inc. Insider Trades
Insidersalg ACAD / ACADIA Pharmaceuticals Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ACAD / ACADIA Pharmaceuticals Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Glenn Baity som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2018-04-20 2018-04-18 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 28.125 28.125
2018-01-31 2018-01-29 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -36.558 83.734 -30,39 32,39 -1.184.055 2.712.010
2018-01-11 2018-01-10 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -50.179 0 -100,00
2018-01-11 2018-01-10 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 50.179 120.292 71,57 2,18 109.390 262.237
2018-01-04 2018-01-02 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -74.321 0 -100,00
2018-01-04 2018-01-02 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -74.321 70.113 -51,46 30,14 -2.240.139 2.113.304
2018-01-04 2018-01-02 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 74.321 144.434 106,00 2,18 162.020 314.866
2017-10-06 2017-10-05 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -20.000 0 -100,00
2017-10-06 2017-10-05 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -7.500 0 -100,00
2017-10-06 2017-10-05 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -1.000 124.500 -0,80
2017-10-06 2017-10-05 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -37.500 69.656 -35,00 40,91 -1.534.042 2.849.474
2017-10-06 2017-10-05 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 20.000 107.156 22,95 2,00 40.000 214.312
2017-10-06 2017-10-05 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 7.500 99.656 8,14 1,62 12.150 161.443
2017-10-06 2017-10-05 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 1.000 79.656 1,27 2,18 2.180 173.650
2017-10-06 2017-10-04 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -4.500 125.500 -3,46
2017-10-06 2017-10-04 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -6.500 7.500 -46,43
2017-10-06 2017-10-04 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 4.500 78.656 6,07 2,18 9.810 171.470
2017-10-06 2017-10-04 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 6.500 74.156 9,61 1,62 10.530 120.133
2017-09-08 2017-09-07 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 46.875 46.875
2017-09-01 2017-08-30 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -16.507 14.000 -54,11
2017-09-01 2017-08-30 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -26.507 67.656 -28,15 34,87 -924.315 2.359.205
2017-09-01 2017-08-30 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 16.507 94.163 21,26 1,62 26.741 152.544
2017-08-11 2017-08-09 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -13.400 30.507 -30,52
2017-08-11 2017-08-09 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -922 0 -100,00
2017-08-11 2017-08-09 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -14.322 77.656 -15,57 34,88 -499.534 2.708.548
2017-08-11 2017-08-09 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 13.400 91.978 17,05 1,62 21.708 149.004
2017-08-11 2017-08-09 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 922 78.578 1,19 1,55 1.429 121.796
2017-08-08 2017-08-04 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -6.500 43.907 -12,90
2017-08-08 2017-08-04 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 6.500 77.656 9,13 1,62 10.530 125.803
2017-07-21 2017-07-20 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -28.097 28.000 -50,09
2017-07-21 2017-07-20 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -38.097 71.156 -34,87 30,00 -1.142.910 2.134.680
2017-07-21 2017-07-20 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 28.097 109.253 34,62 1,62 45.517 176.990
2017-06-26 2017-06-22 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -1.903 56.097 -3,28
2017-06-26 2017-06-22 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -1.903 81.156 -2,29 30,00 -57.091 2.434.712
2017-06-26 2017-06-22 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 1.903 83.059 2,34 1,62 3.083 134.556
2017-05-17 2017-05-15 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -14.093 58.000 -19,55
2017-05-17 2017-05-15 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 14.093 81.156 21,01 1,62 22.831 131.473
2017-03-10 2017-03-08 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 46.875 46.875
2017-02-16 2017-02-14 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -6.365 0 -100,00
2017-02-16 2017-02-14 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -3.224 0 -100,00
2017-02-16 2017-02-14 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -16.776 0 -100,00
2017-02-16 2017-02-14 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -26.365 67.063 -28,22 39,66 -1.045.517 2.659.417
2017-02-16 2017-02-14 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 6.365 93.428 7,31 1,64 10.439 153.222
2017-02-16 2017-02-14 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 20.000 87.063 29,82 8,32 166.400 724.364
2017-02-03 2017-02-01 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -21.078 0 -100,00
2017-02-03 2017-02-01 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -31.078 67.063 -31,67 35,15 -1.092.382 2.357.244
2017-02-03 2017-02-01 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 21.078 98.141 27,35 1,55 32.671 152.119
2016-12-29 2016-12-28 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -5.500 72.093 -7,09
2016-12-29 2016-12-28 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 5.500 77.063 7,69 1,62 8.910 124.842
2016-12-29 2016-12-27 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -9.800 21.078 -31,74
2016-12-29 2016-12-27 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -9.800 71.563 -12,04 30,46 -298.474 2.179.559
2016-12-29 2016-12-27 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 9.800 81.363 13,69 1,55 15.190 126.113
2016-12-21 2016-12-20 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 30.878 -24,46
2016-12-21 2016-12-20 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 71.563 -12,26 30,00 -300.001 2.146.897
2016-12-21 2016-12-20 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 81.563 13,97 1,55 15.500 126.423
2016-12-21 2016-12-19 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -8.635 0 -100,00
2016-12-21 2016-12-19 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 8.635 71.563 13,72 1,64 14.161 117.363
2016-11-14 2016-11-10 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.200 40.878 -19,97
2016-11-14 2016-11-10 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -10.200 62.921 -13,95 30,07 -306.687 1.891.871
2016-11-14 2016-11-10 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.200 73.121 16,21 1,55 15.810 113.338
2016-07-13 2016-07-12 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2.625 0 -100,00
2016-07-13 2016-07-12 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -3.375 0 -100,00
2016-07-13 2016-07-12 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -645 0 -100,00
2016-07-13 2016-07-12 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -5.298 0 -100,00
2016-07-13 2016-07-12 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -11.943 62.921 -15,95 35,00 -418.031 2.202.373
2016-07-13 2016-07-12 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 2.625 74.864 3,63 6,78 17.798 507.578
2016-07-13 2016-07-12 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 3.375 72.239 4,90 6,78 22.882 489.780
2016-07-13 2016-07-12 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 645 68.864 0,95 6,78 4.373 466.898
2016-07-13 2016-07-12 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 5.298 68.219 8,42 6,78 35.920 462.525
2016-07-13 2016-07-11 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -4.057 5.298 -43,37
2016-07-13 2016-07-11 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -4.057 62.921 -6,06 35,00 -142.001 2.202.336
2016-07-13 2016-07-11 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 4.057 66.978 6,45 6,78 27.506 454.111
2016-03-17 2016-03-15 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 150.000 150.000
2016-03-04 2016-03-02 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -7.000 0 -100,00
2016-03-04 2016-03-02 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -7.000 62.921 -10,01 20,80 -145.580 1.308.574
2016-03-04 2016-03-02 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 7.000 69.921 11,13 15,37 107.590 1.074.686
2015-03-24 2015-03-20 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 120.000 120.000
2014-12-10 2014-12-09 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -8.000 52.000 -13,33
2014-12-10 2014-12-09 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 8.000 62.423 14,70 1,55 12.400 96.756
2014-09-09 2014-09-05 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 25.000 25.000
2014-03-11 2014-03-07 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 115.000 115.000
2014-02-28 2014-02-26 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -42.000 0 -100,00
2014-02-28 2014-02-26 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -42.000 47.788 -46,78 30,28 -1.271.718 1.446.973
2014-02-28 2014-02-26 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 42.000 89.788 87,89 6,17 259.140 553.992
2013-06-11 2013-06-07 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 130.000 130.000
2013-04-24 2013-04-22 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 22.407 -30,86
2013-04-24 2013-04-22 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 40.000 -20,00 13,15 -131.493 525.972
2013-04-24 2013-04-22 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 50.000 25,00 1,62 16.200 81.000
2013-04-17 2013-04-17 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 59.078 -14,48
2013-04-17 2013-04-17 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 40.000 -20,00 12,26 -122.600 490.400
2013-04-17 2013-04-17 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 50.000 25,00 1,55 15.500 77.500
2013-04-17 2013-04-16 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 922 -91,56
2013-04-17 2013-04-16 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 922 -91,56
2013-04-17 2013-04-16 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -20.000 40.000 -33,33 12,30 -246.000 492.000
2013-04-17 2013-04-16 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 60.000 20,00 1,55 15.500 93.000
2013-04-17 2013-04-16 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 60.000 20,00 1,55 15.500 93.000
2013-04-17 2013-04-15 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 10.922 -47,80
2013-04-17 2013-04-15 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 10.922 -47,80
2013-04-17 2013-04-15 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -20.000 40.000 -33,33 12,50 -250.000 500.000
2013-04-17 2013-04-15 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 60.000 20,00 1,55 15.500 93.000
2013-04-17 2013-04-15 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 60.000 20,00 1,55 15.500 93.000
2013-04-12 2013-04-12 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 32.407 -23,58
2013-04-12 2013-04-12 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 32.407 -23,58
2013-04-12 2013-04-12 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 20.922 -32,34
2013-04-12 2013-04-12 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 40.000 -20,00 13,00 -130.000 520.000
2013-04-12 2013-04-12 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 50.000 25,00 1,62 16.200 81.000
2013-04-12 2013-04-12 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -20.000 40.000 -33,33 12,74 -254.800 509.600
2013-04-12 2013-04-12 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 60.000 20,00 1,55 15.500 93.000
2013-04-12 2013-04-12 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 60.000 20,00 1,55 15.500 93.000
2013-04-12 2013-04-11 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 42.407 -19,08
2013-04-12 2013-04-11 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 42.407 -19,08
2013-04-12 2013-04-11 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 30.922 -24,44
2013-04-12 2013-04-11 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 40.000 -20,00 13,00 -130.000 520.000
2013-04-12 2013-04-11 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 50.000 25,00 1,62 16.200 81.000
2013-04-12 2013-04-11 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 40.000 -20,00 12,00 -120.000 480.000
2013-04-12 2013-04-11 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 50.000 25,00 1,55 15.500 77.500
2013-04-12 2013-04-11 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 50.000 25,00 1,55 15.500 77.500
2013-04-12 2013-04-11 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 40.000 -20,00 11,06 -110.600 442.400
2013-04-03 2013-04-02 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -13.163 40.000 -24,76 8,00 -105.304 320.000
2012-11-29 2012-11-28 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -4.396 43.163 -9,24 5,25 -23.090 226.718
2012-11-29 2012-11-27 4 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
S - Sale X -16.206 47.559 -25,42 6,28 -101.754 298.613
2012-03-26 2012-03-23 4 ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 130.000 130.000
2012-03-26 2012-03-23 4/A ACAD ACADIA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 130.000 130.000
2010-03-16 3 ACAD ACADIA PHARMACEUTICALS INC
Common Stock
30.203
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)